• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Study Endorses HPV Testing for All Women Over 30

Article

New DNA tests looking for the virus responsible for most cases of cervical cancer make sense for all women aged 30 or over, since they can prevent more cases of cancer than smear tests alone, Dutch researchers said on Thursday.

Results of a 5-year study involving 45,000 women provided the strongest evidence yet in favor of using human papillomavirus (HPV) testing, Chris Meijer and colleagues from the VU University Medical Centre in Amsterdam reported in The Lancet Oncology.

Most cases of infection with the sexually transmitted virus are cleared naturally by the immune system, but persistent infection with certain HPV strains can lead to cervical cancer.

The researchers, who looked at women aged 29 to 56, said use of HPV tests led to earlier detection of pre-cancerous lesions, allowing for treatment that improved protection against cancer.

Read more at: http://www.reuters.com/article/2011/12/15/us-hpv-idUSTRE7BE00320111215

Source: Reuters

Related Videos
Dr Susan Vadaparampil
Luke Messac at ISC 2026
2 experts are featured in this series.
Ava Liberman at ISC 2026
Alison Holman at ISC 2026
Dr Ameet Patel
Linda Stein Gold, MD
Eric Levin, Scripta
Dr. Emily Fisher at ISC 2026
© 2026 MJH Life Sciences
AJMC®
All rights reserved.